Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel
Enrolling By Invitation
18 years - 99 years
All
2 participants needed
1 Location
Brief description of study
Participants invited to participate in a research study must have diagnosis of multiple myeloma and have been previously treated with the study drug, cilta-cel. The purpose of this research is to monitor the health status of subjects who were previously enrolled in cilta-cel.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: myeloma
-
Age: 18 years - 99 years
-
Gender: All
Updated on
11 Oct 2024.
Study ID: 850401
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
